News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
798,984 Results
Type
Article (80854)
Company Profile (396)
Press Release (717714)
Multimedia
Podcasts (187)
Webinars (28)
Section
Business (207210)
Career Advice (3512)
Deals (37723)
Drug Delivery (151)
Drug Development (88564)
Employer Resources (194)
FDA (17994)
Job Trends (16473)
News (364187)
Policy (38057)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (1)
Accelerated approval (37)
Adcomms (36)
Allergies (155)
Alliances (52752)
ALS (184)
Alzheimer's disease (1818)
Antibody-drug conjugate (ADC) (357)
Approvals (18181)
Artificial intelligence (610)
Autoimmune disease (179)
Automation (44)
Bankruptcy (383)
Best Places to Work (12428)
BIOSECURE Act (23)
Biosimilars (209)
Biotechnology (259)
Bladder cancer (167)
Brain cancer (66)
Breast cancer (680)
Cancer (5173)
Cardiovascular disease (462)
Career advice (2999)
Career pathing (42)
CAR-T (314)
CDC (64)
Celiac Disease (2)
Cell therapy (837)
Cervical cancer (38)
Clinical research (75062)
Collaboration (1887)
Company closure (4)
Compensation (1210)
Complete response letters (78)
COVID-19 (2994)
CRISPR (105)
C-suite (936)
Cystic fibrosis (154)
Data (6487)
Decentralized trials (2)
Denatured (61)
Depression (158)
Diabetes (544)
Diagnostics (7186)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (289)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (249)
Earnings (83870)
Editorial (68)
Employer branding (25)
Employer resources (167)
Events (120566)
Executive appointments (1058)
FDA (21271)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1594)
Gene editing (224)
Generative AI (53)
Gene therapy (680)
GLP-1 (1147)
Government (5380)
Grass and pollen (8)
Guidances (388)
Healthcare (20747)
HIV (68)
Huntington's disease (51)
IgA nephropathy (89)
Immunology and inflammation (306)
Immuno-oncology (70)
Indications (118)
Infectious disease (3302)
Inflammatory bowel disease (215)
Inflation Reduction Act (16)
Influenza (129)
Intellectual property (263)
Interviews (668)
IPO (17549)
IRA (60)
Job creations (4411)
Job search strategy (2436)
JPM (71)
Kidney cancer (17)
Labor market (90)
Layoffs (661)
Leadership (42)
Legal (9452)
Liver cancer (99)
Longevity (16)
Lung cancer (699)
Lymphoma (393)
Machine learning (44)
Management (65)
Manufacturing (881)
MASH (179)
Medical device (14875)
Medtech (14933)
Mergers & acquisitions (21288)
Metabolic disorders (1441)
Multiple sclerosis (174)
NASH (23)
Neurodegenerative disease (368)
Neuropsychiatric disorders (106)
Neuroscience (3189)
Neurotech (1)
NextGen: Class of 2026 (7427)
Non-profit (5077)
Now hiring (67)
Obesity (705)
Opinion (342)
Ovarian cancer (172)
Pain (220)
Pancreatic cancer (243)
Parkinson's disease (307)
Partnered (38)
Patents (534)
Patient recruitment (523)
Peanut (62)
People (62849)
Pharmaceutical (82)
Pharmacy benefit managers (33)
Phase 1 (23055)
Phase 2 (32649)
Phase 3 (24684)
Pipeline (5615)
Policy (346)
Postmarket research (3373)
Preclinical (10175)
Press Release (69)
Prostate cancer (255)
Psychedelics (60)
Radiopharmaceuticals (303)
Rare diseases (959)
Real estate (6699)
Recruiting (80)
Regulatory (28099)
Reports (58)
Research institute (2714)
Resumes & cover letters (561)
Rett syndrome (28)
RNA editing (21)
RSV (90)
Schizophrenia (162)
Series A (265)
Series B (205)
Service/supplier (19)
Sickle cell disease (105)
Special edition (28)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4075)
State (2)
Stomach cancer (21)
Supply chain (114)
Tariffs (101)
The Weekly (124)
Vaccines (1177)
Venture capital (101)
Weight loss (481)
Women's health (99)
Worklife (22)
Date
Today (149)
Last 7 days (612)
Last 30 days (2501)
Last 365 days (31937)
2026 (4286)
2025 (32285)
2024 (37254)
2023 (42171)
2022 (53493)
2021 (58212)
2020 (57127)
2019 (50724)
2018 (38628)
2017 (36153)
2016 (36203)
2015 (41661)
2014 (35004)
2013 (32759)
2012 (33030)
2011 (33302)
2010 (32367)
Location
Africa (1138)
Alabama (91)
Alaska (7)
Arizona (309)
Arkansas (14)
Asia (47850)
Australia (8356)
California (11748)
Canada (3380)
China (1203)
Colorado (490)
Connecticut (515)
Delaware (352)
Europe (111479)
Florida (1757)
Georgia (375)
Hawaii (4)
Idaho (68)
Illinois (953)
India (74)
Indiana (547)
Iowa (23)
Japan (452)
Kansas (134)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1473)
Massachusetts (8586)
Michigan (349)
Minnesota (667)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (28)
Nevada (128)
New Hampshire (86)
New Jersey (3139)
New Mexico (32)
New York (3103)
North Carolina (1618)
North Dakota (10)
Northern California (5712)
Ohio (358)
Oklahoma (23)
Oregon (45)
Pennsylvania (2349)
Puerto Rico (25)
Rhode Island (51)
South America (1517)
South Carolina (69)
South Dakota (1)
Southern California (4574)
Tennessee (181)
Texas (1845)
United States (42176)
Utah (354)
Vermont (1)
Virginia (291)
Washington D.C. (87)
Washington State (976)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
798,984 Results for "st michael s hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide
December 16, 2025
·
9 min read
Career Advice
When Senior Leaders Are Asked To Carry Too Much
With leaner teams and tighter budgets, senior leaders can face tremendous strain as they juggle increased workloads and leadership responsibilities. In this column, Kaye/Bassman’s Michael Pietrack discusses how pressure builds and what can ease it.
February 18, 2026
·
5 min read
·
Michael Pietrack
Press Releases
IBA signs contract for a three-room Proteus®PLUS solution to be installed at the Seoul St. Mary’s Hospital
December 29, 2025
·
3 min read
Leadership
The Four Employment Agreement Questions Every Pharma Executive Must Ask
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to employment attorney Howard Matalon, JD, partner at OlenderFeldman, on how to evaluate the fine print of an employment agreement.
December 18, 2025
·
6 min read
·
Michael Pietrack
Press Releases
St. Jude Children’s Research Hospital and ALSAC Announce New Board Members
November 20, 2025
·
6 min read
Press Releases
TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors
February 10, 2026
·
7 min read
Business
St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from St. Michael’s Hospital, a site of Unity Health Toronto, has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
April 16, 2024
·
5 min read
Press Releases
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
February 19, 2026
·
5 min read
Leadership
Leadership Lab: How To Spot When Employees Are About To Walk Away
Employees rarely leave companies for one reason alone. In this column, Kaye/Bassman’s Michael Pietrack shares a framework that helps leaders identify when their team members are thinking about heading for the exit—and how to address it.
October 22, 2025
·
7 min read
·
Michael Pietrack
Press Releases
EyePoint Appoints Michael Campbell as Chief Commercial Officer
February 18, 2026
·
10 min read
1 of 79,899
Next